Lv4
420 积分 2023-11-04 加入
High prevalence of chronic kidney disease in population-based patients diagnosed with type 2 diabetes in downtown Shanghai
1天前
已完结
Prevalence of chronic kidney disease and associated factors in Chinese individuals with type 2 diabetes: Cross-sectional study
1天前
已完结
Atrasentan shows positive interim results in IgA nephropathy: ALIGN phase 3 trial
1天前
已关闭
Efficacy and Safety of SGLT-2 Inhibitors in Patients With and Without Advanced CKD: A Systematic Review and Meta-Analysis
1天前
已完结
Sacituzumab tirumotecan in advanced non-small-cell lung cancer with or without EGFR mutations: phase 1/2 and phase 2 trials
7天前
已完结
Ivonescimab versus pembrolizumab for PD-L1-positive non-small cell lung cancer (HARMONi-2): a randomised, double-blind, phase 3 study in China
1个月前
已完结
Ivonescimab in advanced NSCLC: is progression-free survival enough, or are overall survival data also needed?
1个月前
已关闭
Design of a Fc-engineered tetravalent bispecific antibody targeting PD-1 and VEGF with cooperative biological effects
2个月前
已完结
Chronic kidney disease
2个月前
已完结
皖公网安备34019202002308
